Skip to content

Clinical trials

Phase 2 Adrenoleukodystrophy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adrenoleukodystrophy Phase: Phase 2 Country / region: United States Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Masonic Cancer Center, University of Minnesota2
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
Paul Szabolcs1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adrenoleukodystrophy4
Leukodystrophy, Globoid Cell3
Leukodystrophy, Metachromatic3
Metabolism, Inborn Errors2
Mucopolysaccharidoses2
Mucopolysaccharidosis I2
Mucopolysaccharidosis II2
Sphingolipidoses2
alpha-Mannosidosis2
Anemia, Diamond-Blackfan1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.